UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): August 27, 2004
PAINCARE HOLDINGS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
| | | | |
FLORIDA | | 1-14160 | | (06-1110906) |
(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION) | | (COMMISSION FILE NUMBER) | | (IRS EMPLOYER IDENTIFICATION NUMBER) |
37 N. ORANGE AVENUE, SUITE 500
ORLANDO, FLORIDA 32801
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES INCLUDING ZIP CODE)
(407) 926-6615
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)
(407) 926-6616
(REGISTRANT’S FACSIMILE NUMBER, INCLUDING AREA CODE)
WWW.PAINCAREHOLDINGS.COM
(REGISTRANT’S WEBSITE ADDRESS)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS
On June 12, 2004 we announced that we completed a merger with Benjamin Zolper, M.D., LLC, d/b/a Northeast Pain Management (the “Zolper”), a Maine based private physician group specializing in pain management. The capital stock of “Zolper” was acquired in a merger transaction from Benjamin Zolper, M.D., the sole shareholder. Dr. Zolper has no prior relationship with us.
Total consideration which may be paid to the shareholder is $3,500,000, with 50% of such consideration to be paid in cash and 50% in PainCare’s common stock. One-half of the purchase price ($1,750,000) was paid at closing with the remaining one-half of the merger consideration ($1,750,000) payable pro-rata over three years pursuant to a strict “earn out formula” in which PainCare must realize $700,000 per year in net operating income. PainCare will fund the cash portion of the initial purchase price from the proceeds of the recently completed $5,000,000 follow-on financing by Laurus Master Fund, Ltd.
The acquisition has been accounted for using the purchase method of accounting.
ITEM 9.01 FINANCIAL STATEMENT AND EXHIBITS
The following financial statements, pro forma information and exhibits are filed as part of this report.
(a) Financial Statements of Business Acquired
Benjamin Zolper, M.D., LLC, d/b/a Northeast Pain Management
Report of Independent Certified Public Accountants
2003 Financial Statements:
| • | Balance Sheet as of December 31, 2003 |
| • | Statement of Operations and Retained Earnings for the year ended December 31, 2003 |
| • | Statement of Cash Flows for the year ended December 31, 2003 |
Notes to Financial Statements
(b) Pro forma financial information:
| • | Introduction to Unaudited Pro Forma Condensed Consolidated Financial Information |
| • | Unaudited Pro Forma Condensed Consolidated Balance Sheet as of December 31, 2003 |
| • | Unaudited Pro Forma Condensed Consolidated Statement of Operations for the twelve months ended December 31, 2003 |
Page 2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PAINCARE HOLDINGS, INC.
| | | | |
| | |
Date: August 30, 2004 | | BY: | | /s/ RANDY LUBINSKY
|
| | | | Chief Executive Officer and Director |
| | |
Date: August 30, 2004 | | BY: | | /s/ MARK SZPORKA
|
| | | | Chief Financial & Accounting Officer, Secretary and Director |
Page 3
Independent Auditors’ Report
The Board of Directors
Benjamin Zolper, M.D., LLC
d/b/a Northeast Pain Management
We have audited the accompanying balance sheet of Benjamin Zolper, M.D., LLC, d/b/a Northeast Pain Management as of December 31, 2003 and the related statements of operations and member’s equity, and cash flows for the year then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatements. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Benjamin Zolper, M.D., LLC, d/b/a Northeast Pain Management at December 31, 2003 and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.
Tschopp, Whitcomb & Orr, P.A.
August 24, 2004
Maitland, Florida
Page 4
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Balance Sheet
December 31, 2003
| | | |
Assets | | | |
| |
Current assets: | | | |
Cash | | $ | 38,303 |
Patient accounts receivable, net of contractual reserves and doubtful accounts of $442,896 | | | 347,990 |
| |
|
|
Total current assets | | | 386,293 |
| |
|
|
Property and equipment, net (notes 2 and 3) | | | 117,023 |
| |
|
|
Total assets | | $ | 503,316 |
| |
|
|
Liabilities and Member’s Equity | | | |
| |
Current liabilities: | | | |
Line of credit (note 3) | | $ | 5,471 |
Accounts payable and accrued expenses | | | 18,446 |
Current installments of long-term debt (note 3) | | | 23,413 |
| |
|
|
Total current liabilities | | | 47,330 |
| |
Long-term debt, excluding current installments (note 3) | | | 64,967 |
| |
|
|
Total liabilities | | | 112,297 |
| |
|
|
Commitments and contingencies (notes 3, 4,5 and 6)) | | | |
| |
Members’ equity | | | 391,019 |
| |
|
|
Total liabilities and members’ equity | | $ | 503,316 |
| |
|
|
See accompanying notes to financial statements.
Page 5
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Statement of Operations and Member’s Equity
Year ended December 31, 2003
| | | | |
Net patient revenue | | $ | 1,041,783 | |
Cost of patient revenue | | | 234,573 | |
| |
|
|
|
Gross profit | | | 807,210 | |
General and administrative expenses | | | 201,092 | |
| |
|
|
|
Operating income | | | 606,118 | |
| |
Other expenses: | | | | |
Interest | | | 6,550 | |
Depreciation | | | 18,003 | |
| |
|
|
|
Total other expenses | | | 24,553 | |
| |
|
|
|
Net income | | | 581,565 | |
Member’s equity at beginning of year | | | 160,237 | |
Distributions to member | | | (350,783 | ) |
| |
|
|
|
Member’s equity at end of year | | $ | 391,019 | |
| |
|
|
|
See accompanying notes to financial statements.
Page 6
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Statement of Cash Flows
Year Ended December 31, 2003
| | | | |
Cash flows from operating activities: | | | | |
Net income | | $ | 581,565 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | |
Depreciation | | | 18,003 | |
Cash provided by (used for) changes in: | | | | |
Patient accounts receivable | | | (212,090 | ) |
Accounts payable and accrued expenses | | | 18,446 | |
| |
|
|
|
Net cash provided by operating activities | | | 405,924 | |
| |
|
|
|
Cash flow from investing activities: | | | | |
Purchase of property and equipment | | | (135,026 | ) |
| |
|
|
|
Net cash used in investing activities | | | (135,026 | ) |
| |
|
|
|
Cash flows from financing activities: | | | | |
Proceeds from line of credit, net | | | 5,471 | |
Repayment of long-term debt | | | (13,620 | ) |
Proceeds from long-term debt | | | 102,000 | |
Distributions to member | | | (350,783 | ) |
| |
|
|
|
Net cash used in financing activities | | | (256,932 | ) |
| |
|
|
|
Net increase in cash | | | 13,966 | |
Cash at beginning of year | | | 24,337 | |
| |
|
|
|
Cash at end of year | | $ | 38,303 | |
| |
|
|
|
Supplemental disclosures of cash flow information: | | | | |
Cash paid for interest | | $ | 6,550 | |
| |
|
|
|
See accompanying notes to financial statements.
Page 7
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Notes to Financial Statements
December 31, 2003
(1) | Organization and Summary of Significant Accounting Policies |
| (a) | Organization and Mission |
Benjamin Zolper, M.D., LLC was organized in the State of Maine in December 2001 for the purpose of providing quality medical treatment to the Bangor, Maine area.
Patient revenue is recognized at the time the service is performed at the estimated net realizable amounts from patients, third-party payors and others for services rendered. The Company is a provider under the Medicare program and various other third-party payor arrangements which provide for payments to the Company at amounts different from its established rates. Provisions for estimated third-party payor settlements, if necessary, are provided in the period the related services are rendered.
Benjamin Zolper, M.D., LLC has been organized as a limited liability company. As such, Benjamin Zolper, M.D., LLC is not a tax paying entity for Federal or state income tax purposes. Accordingly, the accompanying financial statements do not contain a provision for income taxes as the net income or loss of Benjamin Zolper, M.D., LLC is included in the member’s income tax return.
| (d) | Financial Instruments Fair Value, Concentration of Business and Credit Risks |
The carrying amount reported in the balance sheet for cash, accounts receivable, accounts payable and accrued expenses approximates fair value because of the immediate or short-term maturity of these financial instruments. The carrying amount reported in the accompanying balance sheets for line of credit and long-term debt approximates fair value because the actual interest rates do not significantly differ from current rates offered for instruments with similar characteristics. Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of patient accounts receivable which amount to approximately $350,000. The Company performs credit evaluations of its
(Continued)
Page 8
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Notes to Financial Statements
December 31, 2003
(1) | Organization and Summary of Significant Accounting Policies – (Continued) |
| (d) | Financial Instruments Fair Value, Concentration of Business and Credit Risks – (Continued) |
patients prior to rendering service and generally does not require collateral. The majority of the Company’s patients are covered by third party payors such as insurance companies and Medicare. For the year ended December 31, 2003 the percentage of revenue derived from significant third party payors was as follows:
| | |
Blue Cross of Maine | | 19% |
Medicare | | 32% |
Management of the Company has made certain estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these financial statements in conformity with generally accepted accounting principles. Actual results could differ from those estimates.
For purposes of cash flows, cash and cash equivalents include cash on hand, cash on deposit (including interest bearing accounts) and short-term financial instruments with a maturity, from the date of purchase, of three months or less.
(2) | Property and Equipment |
Property and equipment consists of the following at December 31, 2003:
| | | | |
Leasehold improvements | | $ | 12,000 | |
Computer equipment and software | | | 3,390 | |
Furniture and fixtures | | | 17,636 | |
Medical and therapy equipment | | | 102,000 | |
| |
|
|
|
| | | 135,026 | |
Less accumulated depreciation | | | (18,003 | ) |
| |
|
|
|
| | $ | 117,023 | |
| |
|
|
|
Page 9
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Notes to Financial Statements
December 31, 2003
(3) | Line of Credit and Long-Term Debt |
Long-term debt consists of the following at December 31, 2003:
| | | |
Note payable with monthly principal payments of $2,524, plus interest at 8.8% through May, 2007, collateralized by medical equipment. | | $ | 88,380 |
Less current installments | | | 23,413 |
| |
|
|
| | $ | 64,967 |
| |
|
|
Future maturities of long-term debt are as follows:
| | | |
2004 | | $ | 23,413 |
2005 | | | 25,564 |
2006 | | | 27,912 |
2007 | | | 11,491 |
The Company has a line of credit with a bank which bears interest at the bank’s prime interest plus 1% rate (5.0% at December 31, 2003) and has a maximum borrowing capacity of $100,000. The outstanding balance under this line at December 31, 2003 was $5,471.
The Company is obligated under a non-cancellable operating lease with related party for its office facilities and various equipment. Future minimum lease payments under the Company’s non-cancellable operating lease as of December 31, 2003 are as follows:
| | | |
Year ending December 31,
| | |
2004 | | $ | 55,800 |
2005 | | | 23,750 |
Total rent expense for the year ended December 31, 2003 was $48,000.
Page 10
BENJAMIN ZOLPER, M.D., LLC
D/B/A NORTHEAST PAIN MANAGEMENT
Notes to Financial Statements
December 31, 2003
Third-Party Payor Settlements
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors and others for services rendered. The Company is a provider under Blue Cross, Medicare and various other third-party payor arrangements which provide for payments to the Clinic at amounts different from its established rates. Provisions for estimated third-party payor settlements, if necessary, are provided in the period the related services are rendered.
Medical Malpractice Claims
The Company is subject to claims and legal actions primarily as a result of medical malpractice matters which arise in the ordinary course of business. The Company maintains malpractice insurance to protect against such claims or legal actions. Management believes the ultimate resolution of such matters will be adequately covered by the Company’s insurance and will not have a material adverse effect on its financial position or results of operations.
In July, 2004, the Company completed a merger with PainCare Holdings, Inc. (“PainCare”). The merger required the owner to sell the capital stock of the practice to PainCare for $3,500,000. $875,000 of the purchase price was paid in cash and $875,000 paid in PainCare stock at closing. The remaining $1,750,000 will be paid as 50% cash and 50% PainCare stock over a three year period assuming certain earning thresholds are met.
Page 11
PAINCARE HOLDINGS, INC.
Unaudited Pro Forma Consolidated Balance Sheet
As of December 31, 2003
| | | | | | | | | | | | | | |
| | PainCare Historical Statements
| | Zolper Historical Statements
| | | Pro forma Adjustments
| | | Pro forma
|
Assets | | | | | | | | | | | | | | |
Current Assets: | | | | | | | | | | | | | | |
Cash (1) | | $ | 7,923,767 | | $ | 38,303 | | | $ | (875,000 | ) | | $ | 7,087,070 |
Accounts receivable | | | 5,100,699 | | | 347,990 | | | | — | | | | 5,448,689 |
Due from shareholder | | | 203,050 | | | — | | | | — | | | | 203,050 |
Note receivable | | | 320,353 | | | — | | | | — | | | | 320,353 |
Deposits & prepaid expenses | | | 514,957 | | | — | | | | — | | | | 514,957 |
| |
|
| |
|
|
| |
|
|
| |
|
|
Total current assets | | | 14,062,826 | | | 386,293 | | | | (875,000 | ) | | | 13,574,119 |
| | | | |
Property and equipment, net | | | 4,730,723 | | | 117,023 | | | | — | | | | 4,847,746 |
Goodwill, net (1) | | | 21,946,735 | | | — | | | | 1,265,130 | | | | 23,211,865 |
Other assets | | | 2,680,665 | | | — | | | | — | | | | 2,680,665 |
| |
|
| |
|
|
| |
|
|
| |
|
|
Total assets | | $ | 43,420,949 | | $ | 503,316 | | | $ | 390,130 | | | $ | 44,314,395 |
| | | | |
Liabilities and Stockholder’s Equity | | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | | |
Accounts payable & accrued expenses | | $ | 639,668 | | $ | 18,446 | | | $ | — | | | $ | 658,114 |
Line of Credit | | | — | | | 5,471 | | | | (5,471 | ) | | | — |
Current portion of notes payable | | | 4,216,566 | | | 23,413 | | | | (23,413 | ) | | | 4,216,566 |
Current portion of convertible debenture | | | 306,616 | | | — | | | | — | | | | 306,616 |
Current portion of lease payable | | | 578,557 | | | — | | | | — | | | | 578,557 |
| |
|
| |
|
|
| |
|
|
| |
|
|
Total current liabilities | | | 5,741,407 | | | 47,330 | | | | (28,884 | ) | | | 5,759,853 |
| | | | |
Notes payable, less current portion 510,141 | | | 64,967 | | | (64,967 | ) | | | 510,141 | | | | |
Convertible debentures | | | 10,712,000 | | | — | | | | — | | | | 10,712,000 |
Deferred income tax liability | | | 683,300 | | | — | | | | — | | | | 683,300 |
Lease payable | | | 2,300,165 | | | — | | | | — | | | | 2,300,165 |
| |
|
| |
|
|
| |
|
|
| |
|
|
Total liabilities | | | 19,947,013 | | | 112,297 | | | | (93,851 | ) | | | 19,965,459 |
| | | | |
Stockholder’s equity: | | | | | | | | | | | | | | |
| | | | |
Common stock, $.0001 par value (1) | | | 2,688 | | | — | | | | 32 | | | | 2,720 |
Preferred stock, $.0001 par value | | | — | | | — | | | | — | | | | — |
Additional paid in capital (1) | | | 21,700,894 | | | — | | | | 874,968 | | | | 22,575,862 |
Retained earnings (1) | | | 1,769,393 | | | 391,019 | | | | (391,019 | ) | | | 1,769,393 |
Cumulative translation adjustment | | | 961 | | | — | | | | — | | | | 961 |
| |
|
| |
|
|
| |
|
|
| |
|
|
Total stockholder’s equity | | | 23,473,936 | | | 391,019 | | | | 483,981 | | | | 24,348,936 |
| | | | |
Total liabilities & stockholder’s equity | | $ | 43,420,949 | | $ | 503,316 | | | $ | 390,130 | | | $ | 44,314,395 |
| |
|
| |
|
|
| |
|
|
| |
|
|
See accompanying footnotes to unaudited pro forma financial statements.
Page 12
PAINCARE HOLDINGS, INC.
Unaudited Pro Forma Consolidated Statement of Operations
For the twelve months ended December 31, 2003
| | | | | | | | | | | | | |
| | PainCare Historical Statements
| | Zolper Historical Statements
| | Pro forma Adjustments
| | | Pro forma
|
Revenues | | $ | 14,980,867 | | $ | 1,041,783 | | $ | — | | | $ | 16,022,650 |
Cost of sales (2) | | | 4,586,732 | | | 234,573 | | | (25,361 | ) | | | 4,795,944 |
| |
|
| |
|
| |
|
|
| |
|
|
Gross profit | | | 10,394,135 | | | 807,210 | | | 25,361 | | | | 11,226,706 |
| | | | |
Operating expenses: | | | | | | | | | | | | | |
Selling, general and administrative (3) | | | 7,543,915 | | | 201,092 | | | (85,263 | ) | | | 7,659,744 |
Amortization expense | | | 61,463 | | | — | | | — | | | | 61,463 |
Depreciation expense | | | 463,190 | | | 18,003 | | | — | | | | 481,193 |
| |
|
| |
|
| |
|
|
| |
|
|
Operating income | | | 2,325,567 | | | 588,115 | | | 110,624 | | | | 3,024,306 |
| | | | |
Interest expense | | | 487,786 | | | 6,550 | | | — | | | | 494,336 |
Other income | | | 45,425 | | | — | | | — | | | | 45,425 |
| |
|
| |
|
| |
|
|
| |
|
|
Income before taxes | | | 1,883,206 | | | 581,565 | | | 110,624 | | | | 2,575,395 |
Provision for income taxes (4) | | | 670,300 | | | — | | | 246,419 | | | | 916,719 |
| |
|
| |
|
| |
|
|
| |
|
|
Net income | | $ | 1,212,906 | | $ | 581,565 | | $ | (135,795 | ) | | $ | 1,658,676 |
| |
|
| |
|
| |
|
|
| |
|
|
Basic earnings per share | | | | | | | | | | | | $ | 0.08 |
| | | | | | | | | | | |
|
|
Basic weighted average shares outstanding | | | | | | | | | | | | | 21,089,064 |
| | | | | | | | | | | |
|
|
Diluted earnings per share | | | | | | | | | | | | $ | 0.07 |
| | | | | | | | | | | |
|
|
Diluted weighted average shares outstanding | | | | | | | | | | | | | 24,283,874 |
| | | | | | | | | | | |
|
|
See accompanying footnotes to unaudited pro forma financial statements.
Page 13
Footnotes to Unaudited Pro Forma Financial Statements
(1) | Represents the impact of the purchase of the outstanding shares of Benjamin Zolper, M.D., LLC, d/b/a Northeast Pain Management, including the issuance of 316,444 shares of PainCare Holdings, Inc. common stock at $2.7651 per share and the resulting goodwill of $1,265,130 using the purchase method of accounting. |
(2) | Adjustment for non-recurring compensation paid to Dr. Zolper. |
(3) | Adjustment for non-recurring general and administrative expenses. |
(4) | Adjustment for estimated income tax liability based on an income tax rate of 35.6%. |
Page 14